Allergen specificity of IgG4-expressing B cells in patients with grass pollen allergy undergoing immunotherapy
about
Potential Mechanisms for IgG4 Inhibition of Immediate Hypersensitivity ReactionsIgG4 Characteristics and Functions in Cancer ImmunityThe Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen ImmunotherapyHuman IgG4: a structural perspectiveThe human IgE repertoireAllergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageinA tool kit for rapid cloning and expression of recombinant antibodies."Auto-anti-IgE": naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation.Mechanism of the antigen-independent cytokinergic SPE-7 IgE activation of human mast cells in vitro.IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects.Persistence and evolution of allergen-specific IgE repertoires during subcutaneous specific immunotherapyPhage display peptide libraries in molecular allergology: from epitope mapping to mimotope-based immunotherapy.The contribution of allergen-specific IgG to the development of th2-mediated airway inflammationEpitope specificity determines cross-protection of a SIT-induced IgG4 antibodyIgG4 subclass antibodies impair antitumor immunity in melanoma.Inhibition of allergen-dependent IgE activity by antibodies of the same specificity but different class.Allergen-specific IgG antibodies purified from mite-allergic patients sera block the IgE recognition of Dermatophagoides pteronyssinus antigens: an in vitro study.IgE immunotherapy: a novel concept with promise for the treatment of cancer.Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps.Molecular basis for downregulation of C5a-mediated inflammation by IgG1 immune complexes in allergy and asthma.Variation in allergen content in sublingual allergen immunotherapy with house dust mitesPathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes.Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.Maternal IgG immune complexes induce food allergen-specific tolerance in offspring.Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments.A New Classification System for IgG4 Autoantibodies.Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells.Structure of a patient-derived antibody in complex with allergen reveals simultaneous conventional and superantigen-like recognition
P2860
Q26764848-ECCECD07-43B3-4DD8-AB50-4DE0C1EAC393Q26770244-43574F0E-5448-4E53-8542-EF18B65A7492Q26771289-B7578139-07E9-44D8-9FFE-AD24EA946793Q26779758-74FE5524-7280-47A9-A701-48E7554F9DB7Q26865573-7F445D72-5EC7-4404-BEB4-557166107D18Q28077951-A711AB28-FF99-482A-9101-57A874D87689Q33970343-957DC870-CCE4-4607-8684-922F7B50FA6EQ34647874-56C857DF-4A57-4874-8684-6D73C855C9ECQ35477596-E03D4126-552C-4B8D-A9EE-B847A2011726Q35566586-48213314-2739-4D41-86BD-A50118F9CB6FQ35828399-852DC6D7-6283-4958-BAEF-F6E48F71B330Q35838733-B6326ED1-AE1C-4928-A6F3-D38BBAD7E974Q36061055-F5F0C978-ADA3-4B29-AE9E-11C0A0370049Q36361177-EC9CC2CB-1E29-4257-A5C9-13928285F8A7Q36472423-A2A2B06E-26B2-4D52-B987-0E45E85FF9FBQ36733452-73EF8817-DE1F-476D-94C6-C7C70DC6EE04Q37105631-7CEEAB91-60D7-4072-B332-A42346C13AE3Q37166041-070A4934-ABF2-4D45-BEC1-D0B397B21F96Q37593712-B91CAAE2-EC7D-4C83-A870-BFB441FEB291Q37737520-B11CCF59-BF2B-436A-B26B-EC2D174A972AQ38135285-FF0899EF-ABF7-43EF-9308-4D210D7C9427Q38549315-A196C70A-EC32-44CD-8F5E-09F4F7F88DEBQ38662580-0720F6A9-C876-4C05-AF5D-ABA53AD69773Q42079107-414B04F3-F6CB-4842-8510-671F3A9D8C21Q42692115-942428EF-AEF6-4193-B79D-A7845CD1D7CEQ47574862-97050296-F780-4C4D-9934-3EA5E6B9554EQ50119865-CA457A08-5D10-4D01-9FED-58017E513C99Q50327901-B217A75B-674C-4B62-836D-BBAFE44C25ECQ55279671-3EE57839-0856-4DA9-A910-FF5D4BA4D34DQ58700268-344F8472-99EE-4B2A-98DA-C4FA7DC3648C
P2860
Allergen specificity of IgG4-expressing B cells in patients with grass pollen allergy undergoing immunotherapy
description
im September 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 13 May 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2012
@uk
name
Allergen specificity of IgG4-e ...... lergy undergoing immunotherapy
@en
Allergen specificity of IgG4-e ...... lergy undergoing immunotherapy
@nl
type
label
Allergen specificity of IgG4-e ...... lergy undergoing immunotherapy
@en
Allergen specificity of IgG4-e ...... lergy undergoing immunotherapy
@nl
prefLabel
Allergen specificity of IgG4-e ...... lergy undergoing immunotherapy
@en
Allergen specificity of IgG4-e ...... lergy undergoing immunotherapy
@nl
P2093
P50
P1476
Allergen specificity of IgG(4) ...... lergy undergoing immunotherapy
@en
P2093
Holly Bowen
Mohamed H Shamji
Rosaleen A Calvert
Stephen R Durham
Tihomir S Dodev
P304
663-670.e3
P356
10.1016/J.JACI.2012.04.006
P407
P577
2012-05-13T00:00:00Z